Introduction
Hypertension is the medical condition for having persistently high blood pressure, when our heart has to work harder to push blood around our body. It is a long-term medical condition in which the blood pressure in the arteries is importunately elevated creating a major risk factor for coronary artery disease, stroke, heart failure and peripheral vascular diseases.
Annals of Clinical Hypertension i... Readmore
Current Issue Submission Guidelines Submit Your Manuscipt Archive
Membership
There is a precept- "two heads result in more fruitful thing than one head alone". Heighten Science Publication unique concept of membership is based on this precept. Readmore
Publication fees
Heighten Science Publication (Heighpubs) works with the vision that a published work should be visualized by more and more people for their intellectual benefits. Readmore
Peer Review
Heighten Science Publication Corporation uses Double-Blind Peer Review policy for all the journals. Under this policy both the reviewers and authors identities are concealed... Readmore
Why with Us
Heighten Science has a rich history and track-record of delivering simpler and updated access to the research needs in disciplines of health, science, management and law. Readmore
Enter your
University/Institution
to find colleagues at
Heighten Science Publications
Recent Articles
2021-01-12 Short Communication
Ergün Barış Kaya and Yusuf Ziya Şener*
Abstract
Tyrosine kinase inhibitors (TKIs) are widely used in Oncology practice. Hypertension may develop during cancer treatment and TKIs are well known drugs that are associated with drug related hypertensive toxicity. TKI related hypertensive toxicity is not always the indicator of...
Abstract Read Full Article HTML DOI: 10.29328/journal.ach.1001025 Cite this Article
2020-10-01 Research Article
Blessing Onyinye Ukoha-kalu*, Maxwell Ogochukwu Adibe and Chinwe Victoria Ukwe
Abstract
Background: An event involving drug therapy that actually or potentially interfers with the desired health outcomes is known as drug therapy problem.
Objective: The study aimed to identify and resolve potential drug related problems...
Abstract Read Full Article HTML DOI: 10.29328/journal.ach.1001024 Cite this Article
2020-09-29 Research Article
Blessing Onyinye Ukoha-kalu*, Maxwell Ogochukwu Adibe, Chibueze Anosike and Chinwe Victoria Ukwe
Abstract
Background: Poor knowledge about hypertension can lead to poor attitude towards the disease which may directly affect patients self-care practices towards hypertension.
Objective: This study aimed to assess the knowledge, attitude and practice towards ...
Abstract Read Full Article HTML DOI: 10.29328/journal.ach.1001023 Cite this Article
2020-09-29 Research Article
Sewunet Ademe* and Afework Edmealem
Abstract
Introduction: Hypertension is the leading remediable risk factor for cardiovascular disease, affecting more than 1 billion people worldwide, and is responsible for more than 10 million preventable deaths globally each year. Hypertension can be described as th...
Abstract Read Full Article HTML DOI: 10.29328/journal.ach.1001022 Cite this Article
2020-08-13 Research Article
Marta Brown-Martínez*, Zenaida Hernández, Yamile Valdés, Edilberto González, Emelina Despaigne and Evelio Gonzalez
Abstract
Background: Cerebral small vessel disease and extracranial atherosclerotic carotid disease are manifestations of silent cerebrovascular disease (CVD). Information on these two pathologies in hypertensive population with low cardiovascular risk (CVR) is scarce...
Abstract Read Full Article HTML DOI: 10.29328/journal.ach.1001021 Cite this Article
2019-11-08 Research Article
Guillermo Padrón Arredondo*
Summary
Introduction: Hypertension is a silent pathology in a way that affects all four spheres to be considered as such; magnitude, transcendence vulnerability, and feasibility. The World Health Organization estimates that 45% of deaths from heart disease and 51% of ...
Abstract Read Full Article HTML DOI: 10.29328/journal.ach.1001020 Cite this Article
2019-10-23 Research Article
Adam Ahamat Ali*, Guillaume Mahamat Abderraman*, Zeinabou Maiga Moussa Tondi and Hissein Ali Mahamat
Abstract
Introduction: High blood pressure is a major cardiovascular risk factor. In hypertension, non-compliance is frequent. The objective of this work is to evaluate the therapeutic observances and to identify the predictive factors of poor compliances in Chadian h...
Abstract Read Full Article HTML DOI: 10.29328/journal.ach.1001019 Cite this Article
2019-08-13 Research Article
Kanako Saito, Yukiko Hishiki and Hakuo Takahashi*
Abstract
Objective: The present study aimed to evaluate the accuracy of the Omron HBP-9031C automated oscillometric upper-arm blood pressure (BP) measurement device for blood pressure monitoring, according to the ANSI/AAMI/ISO 81060-2:2013 protocol (ANSI/AAMI/ISO).
Abstract Read Full Article HTML DOI: 10.29328/journal.ach.1001018 Cite this Article
2019-07-24 Research Article
Mohsen Ibrahim M*
Review Article
The European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) jointly developed a series of hypertension guidelines in the years 2003, 207 and 2013. The most recent guidelines were issued by the two societies in August this year (2018) and were...
Abstract Read Full Article HTML DOI: 10.29328/journal.ach.1001017 Cite this Article
2019-06-27 Mini Review
Alexander E Berezin* and Alexander A Berezin
Abstract
Platelet vesiculation is common factor contributing in coagulation and thromboembolism in patients with atrial fibrillation (AF). Platelet-derived vesicles are involved in the coagulation, thromboembolism, microvascular inflammation, arterial stiffness, vascular calcification...
Abstract Read Full Article HTML DOI: 10.29328/journal.ach.1001016 Cite this Article